| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |